Inventurus Knowledge Solutions Limited’s U.S. subsidiary, IKS Health, has announced a definitive agreement to acquire TruBridge, a healthcare technology provider for rural and community hospitals, for $26.25 per share. This strategic acquisition aims to enhance access to high-quality care and support clinicians and hospitals serving communities across the United States.
The acquisition will combine IKS Health’s comprehensive care enablement capabilities with TruBridge’s expertise in revenue cycle management and electronic health record solutions. The merged entity is expected to strengthen local healthcare systems, enabling patients to receive essential care closer to home while enhancing care delivery across the ambulatory and acute care continuum.
Post-acquisition, the combined company will focus on continuous improvement and connected workflows, integrating agentic artificial intelligence with human expertise to address complex operational challenges. The platform will incorporate a broader range of clinical and financial data, designed to become increasingly intelligent and efficient. This intelligence, reinforced by human insight, is anticipated to ensure community hospitals and medical groups have the financial resilience and advanced support needed to focus on patient health.
Sachin K. Gupta, Founder and Global CEO of IKS Health, highlighted the acquisition’s significance, stating, “By welcoming TruBridge, IKS Health is extending its proven, clinician-first experience to the vital rural and community hospital market. This new entity supports our long-term vision of building a comprehensive care ecosystem for all types of healthcare organisations.”
The combined organisation will leverage modern revenue cycle management, predictive analytics, and advanced EHR capabilities to support more than 2,000 healthcare organisations and over 150,000 clinicians. Chris Fowler, President and CEO of TruBridge, expressed enthusiasm for the merger, noting the shared passion for improving provider experiences and financial results.
The acquisition has been approved by the Boards of Directors of IKS Health, IKS, and TruBridge and is expected to close during the third calendar quarter of 2026, subject to customary closing conditions, including shareholder approvals and regulatory notifications. TruBridge’s largest shareholders, representing approximately 27% of its outstanding shares, have agreed to vote in favour of the transaction.
IKS will finance the acquisition primarily through new indebtedness, including a term loan underwritten by Citibank, JPMorganChase, and Deutsche Bank. Solomon Partners Securities, LLC is acting as the exclusive financial advisor to TruBridge, while J.P. Morgan Securities LLC and Citigroup Global Markets India Private Limited are advising IKS Health.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).